Healthtech Startups

Amorphous transforms unstructured hospital data into standardized, queryable formats using AI, enabling hospitals to derive operational, financial, and clinical insights for decision-making. The platform serves hospital operations and finance teams by automating data analysis tasks that typically require manual weeks of work.

1 investor

Amotio develops a guided bone cement removal system with patient-specific surgical planning and precision instrumentation for orthopaedic revision surgery, targeting arthroplasty and revision surgeons who work with cemented joint implants. The medical device company, based in the Netherlands and Wales, is preparing for US commercial launch in the revision arthroplasty market.

1 investor

Amoy Diagnostics develops molecular diagnostic test kits for cancer detection, including PCR, IHC, FISH, and next-generation sequencing products that detect gene mutations such as PIK3CA, KRAS, NRAS, BRAF, and IDH1, as well as microsatellite instability. Its products serve clinical and oncology diagnostics and include related nucleic acid extraction reagents and instruments.

1 investor

Amperos automates and manages insurance claim recovery for healthcare providers, reducing denials and processing backlogs through a combination of automation and expert oversight. The platform helps revenue cycle teams resolve claims with improved consistency and visibility.

1 investor

Ampersand provides a digital platform for remote patient monitoring and clinician communication, enabling healthcare teams to track symptoms, deliver digital therapies, and manage patient care in outpatient settings. The platform includes messaging tools, symptom tracking, medication reminders, and expert-led educational content for patients managing chronic conditions.

1 investor

Amphastar Pharmaceuticals manufactures and distributes generic and branded pharmaceutical products, including injectable medications, inhalation aerosols, and emergency treatments for medical professionals and patients in the United States.

1 investor

1 investor

Amplicore Pharma develops an injectable pharmaceutical formulation targeting musculoskeletal disorders, particularly osteoarthritis, designed to slow cartilage degeneration and reduce symptoms as an alternative to joint replacement surgery.

1 investor

Amplifai develops an AI-powered platform (TFscan) that detects diabetic foot complications in real time to support clinical decision-making and prevent amputations. The system integrates with hospital and clinic infrastructure to provide risk scores and analytics for patient care teams.

1 investor

Amplifire provides adaptive learning software for training healthcare clinicians on Epic electronic health record systems. The platform uses personalized algorithms and analytics to reduce training time while improving EHR proficiency and satisfaction among physicians, nurses, and clinical support staff.

1 investor

Amplifyer develops liquid biopsy technology aimed at improving outcomes for cancer patients. The company operates in the biotech and diagnostics space.

1 investor

1 investor

Amplo Biotechnology develops adeno-associated virus (AAV) gene therapies for genetic diseases of the neuromuscular junction, targeting rare and ultra-rare patient populations such as those with Congenital Myasthenic Syndromes. Its work focuses on delivering proteins like Dok-7 and Collagen Q that are essential to neuromuscular junction function.

1 investor

AMPS provides cost management solutions for self-insured employers, focusing on member experience and expense optimization.

1 investor

AMR Bio develops XF-73, a first-in-class topical antimicrobial candidate in Phase 3 trials designed to prevent post-surgical infections, with the lead program targeting pre-operative decolonization in surgical settings. The company also advances dermal formulations for severe wound and skin infections.

1 investor

AMSlab is a biotechnology company focused on research, development, and innovation in analytical methods and quality control. The company develops solutions for detecting and identifying compounds across healthcare, food safety, marine toxins, and related biotech applications.

1 investor

Amsel Medical develops minimally invasive vessel occlusion devices for vascular surgery, trauma care, and interventional procedures. The company's products, including the SCureClamp iDOT and SCureTOTM, are designed to occlude blood vessels for applications ranging from venous disease treatment to combat hemorrhage control.

1 investor

AMT Medical develops the Elana Anastomotic System, a medical device using a clip and laser catheter to create the distal anastomosis connecting a graft to the coronary artery in coronary bypass (CABG) surgery. The device targets cardiac surgeons and care teams and supports open, off-pump, and minimally invasive procedures including MIDCAB and robotic-assisted TECAB techniques.

1 investor

Amulyte develops a portable monitoring and activity tracking system designed to detect falls and help seniors maintain independent living at home without requiring a fixed base station.

1 investor

AMW GmbH is a specialty pharmaceutical company that develops biodegradable drug delivery systems for controlled release of medications, with production facilities in Germany. It has two approved implant products, Goserelin and Leuprorelin, distributed worldwide through local and global pharmaceutical partners.

1 investor

Amygdala Neurosciences is a biopharmaceutical company developing oral medications to treat alcohol and substance use disorders by targeting the ALDH2 enzyme. The company addresses unmet clinical needs in addiction treatment through novel pharmacotherapies.

1 investor

A drug discovery company focused on medicinal chemistry and preclinical research across multiple therapeutic areas.

1 investor

Everlife Analisa Resources is a laboratory and scientific solutions distributor founded in 1999, providing instruments, chemistries, consumables, software, and technical services to life sciences, analytical testing, and diagnostic markets across Asia. The company serves scientists, research institutions, biotechnology firms, and industries including pharmaceuticals, food, and chemicals.

1 investor

RxList is an online medical resource providing detailed pharmaceutical information on brand and generic drugs, written and reviewed by pharmacists and physicians. The platform serves consumers seeking reliable drug information and pill identification tools.

1 investor